EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities

Jacob Eli García Torres, Norbert Frey, Ashraf Yusuf Rangrez iD

MedComm · 2026-08 · 7 (8)

DOI: 10.1002/mco2.70892 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 07.08.2026. Verfasst von Jacob Eli García Torres und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology Angiology and Pneumology University Hospital Heidelberg Heidelberg Germany. Die Arbeit nennt 254 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer and cardiovascular diseases, the primary causes of mortality globally, are increasingly understood as biologically interconnected rather than distinct pathologies. Recent evidence indicates that protein homeostasis (proteostasis) functions as a crucial molecular link connecting tumor progression, therapeutic resistance, cardiac remodeling, and treatment‐related cardiotoxicity. Proteostasis, which encompasses the cellular processes of protein synthesis, folding, quality control, and degradation, dictates tissue adaptation to chronic stress. Notably, the adaptive mechanisms that allow tumor cells to endure proteotoxic stress and resist therapy are often vital for maintaining cardiac structure and function. Thus, tumor control and cardiovascular injury may be divergent outcomes of a common stress–response framework. In this review, we propose proteostasis as a comprehensive framework for understanding the cancer–cardiovascular interface. We analyze how the ubiquitin–proteasome system, autophagy–lysosome pathway, endoplasmic reticulum stress‐induced unfolded protein response signaling, and molecular chaperone networks are differentially reconfigured in cancer and cardiac tissues, influencing tumor survival, therapeutic susceptibility, and cardiovascular dysfunction. Additionally, we explore the translational implications of proteostasis dysregulation, including mechanisms of anticancer therapy‐induced cardiotoxicity, emerging biomarkers, cardioprotective strategies, and opportunities for precision cardio‐oncology. By conceptualizing efficacy and toxicity as interconnected outcomes of shared proteostasis biology, this review establishes a foundation for developing therapies that optimize cancer control while safeguarding cardiovascular health.

Schlagwörter

Stichwörter der Autor:innen

CVDsER stressautophagycancercardiotoxicitycardio‐oncologydrug repurposingproteostasisubiquitin–proteasome systemunfolded protein response

Autor:innen und Institutionen

  • Department of Cardiology Angiology and Pneumology University Hospital Heidelberg Heidelberg Germany.
  • DZHK (German Centre for Cardiovascular Research) Partner Site Heidelberg Mannheim Germany.

ORCID-Profile: Ashraf Yusuf Rangrez

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

García Torres, J. E., Frey, N., & Rangrez, A. Y. (2026). Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities. MedComm, 7(8). https://doi.org/10.1002/mco2.70892

Vancouver

García Torres JE, Frey N, Rangrez AY. Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities. MedComm. 2026;7(8). doi:10.1002/mco2.70892

BibTeX
@article{GarcaTorres2026,
  author = {García Torres, Jacob Eli and Frey, Norbert and Rangrez, Ashraf Yusuf},
  title = {Cardiovascular Diseases and Cancer: Convergent Proteostasis Networks at the Crossroads of Mechanisms and Therapeutic Opportunities},
  journal = {MedComm},
  year = {2026},
  volume = {7},
  number = {8},
  doi = {10.1002/mco2.70892}
}
Kostenlos starten →